2024-02-08 02:50:26 ET
Summary
- Clorox Co. has shown good results in Q2 2024, with net sales increasing by 16% and adjusted earnings per share increasing by 120% compared to the previous year.
- The company has struggled to grow revenues per share in the last two years, but free cash flow per share has been increasing steadily over the last decade.
- CLX is facing challenges in improving margins and may need to cut dividends if EPS does not grow, making the stock overvalued compared to its peers.
Editor's note: Seeking Alpha is proud to welcome Investment Insight Hub as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Premium. Click here to find out more » ...
Read the full article on Seeking Alpha
For further details see:
Clorox: Relatively Overvalued And Headwinds Put Dividend At Risk